| Capital Markets Industry | Financials Sector | Stanislav Rubakh CEO | OTC PINK Exchange | 45826P309 CUSIP |
| US Country | 1 Employees | - Last Dividend | 21 Apr 2023 Last Split | - IPO Date |
MedWellAI Inc., based in Clearwater, Florida, is a dynamic company that focuses on the development, acquisition, operation, and investment in various businesses. The company leverages cutting-edge artificial intelligence technology to provide innovative healthcare and wellness solutions. It enhances the pharmaceutical distribution landscape through a B2B e-commerce platform, primarily targeting GLP medications that aid in weight loss and diabetes management. The organization, previously known as Integrated Ventures, Inc., rebranded to MedWellAI Inc. in June 2025, marking a significant shift towards healthcare-focused initiatives that cater to a growing demand in the wellness sector.
MedWellAI offers state-of-the-art healthcare solutions powered by artificial intelligence, aiming to provide enhanced patient care and operational efficiency within the healthcare industry.
This platform specializes in distributing pharmaceutical products, ensuring accessibility to vital medications, especially GLP medications that are crucial for weight management and diabetes control. This service enables streamlined ordering for healthcare providers.
The company's ordering system features advanced inventory tracking capabilities, allowing healthcare providers to maintain optimal stock levels. It also incorporates smart suggestions to facilitate efficient inventory management and ordering processes.
MedWellAI extends its services to a variety of healthcare entities, including wellness clinics, med spas, and corporate wellness facilities, providing them with the tools necessary to enhance their service offerings and improve patient outcomes.